PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank18
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P18
Within normal range
vs 2Y Ago
-1.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.14% |
| Q3 2025 | -15.99% |
| Q2 2025 | 32.04% |
| Q1 2025 | 1.64% |
| Q4 2024 | -15.62% |
| Q3 2024 | 37.17% |
| Q2 2024 | -13.46% |
| Q1 2024 | 5.94% |
| Q4 2023 | 13.60% |
| Q3 2023 | 9.05% |
| Q2 2023 | 6.61% |
| Q1 2023 | 3.14% |
| Q4 2022 | -4.98% |
| Q3 2022 | -28.48% |
| Q2 2022 | 37.43% |
| Q1 2022 | -20.58% |
| Q4 2021 | 47.82% |
| Q3 2021 | -16.20% |
| Q2 2021 | -12.32% |
| Q1 2021 | -9.14% |
| Q4 2020 | -3.64% |
| Q3 2020 | 22.83% |
| Q2 2020 | -3.49% |
| Q1 2020 | -8.24% |
| Q4 2019 | -17.16% |
| Q3 2019 | -0.80% |
| Q2 2019 | -12.55% |
| Q1 2019 | -4.78% |
| Q4 2018 | -15.57% |
| Q3 2018 | 2.67% |
| Q2 2018 | -3.57% |
| Q1 2018 | -20.77% |
| Q4 2017 | -19.29% |
| Q3 2017 | 2.34% |
| Q2 2017 | 11.67% |
| Q1 2017 | 10.62% |
| Q4 2016 | -17.46% |
| Q3 2016 | 5.81% |
| Q2 2016 | -7.56% |
| Q1 2016 | 4.14% |